| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |